Long-read DNA/RNA sequencing machine

This solicitation seeks quotes for a turnkey long-read DNA/RNA sequencing machine solution. The Department of Health and Human Services Food and Drug Administration's Center for Biologics Evaluation and Research Division of Cell and Gene Therapy requires this equipment to detect pathogen variants with high confidence, access previously inaccessible genomic regions, and advance genetic research in fields such as host-pathogen interactions. Quotes are due by June 15, 2022 and must include pricing for the sequencing machine as well as trade-in allowances for the offeror's existing Illumina MiSeq, Oxford Nanopore MinION, and Ion Torrent equipment.

This small business set-aside solicitation issued by the Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services. The sequencing machine must meet minimum specifications including average read lengths over 10kb with over 99.9% accuracy, ability to sequence both DNA and RNA from input as low as 10kb in size, and capability to repeatedly sequence the forward and reverse strands of individual molecules. The place of performance is the stated FDA facility in Silver Spring, Maryland. Pricing shall be FOB destination.